Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.
Saved in:
| Title: | Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial. |
|---|---|
| Authors: | Jones RL; Royal Marsden Hospital/Institute of Cancer Research, London, UK. robin.jones4@nhs.net., Groisberg R; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Blay JY; Centre Léon Bérard, the Comprehensive Cancer Centre, Lyon, France., Colman H; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA., De La Fuente M; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Roxburgh P; University of Glasgow, School of Cancer Sciences, Glasgow, UK., Chao MM; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA., Tian H; Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA., Duffaud F; CLIP/CEPCM, Aix-Marseille University (AMU), Marseille, France., Bahleda R; Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France., Van Tine BA; Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA. |
| Source: | Nature communications [Nat Commun] 2026 Jan 29; Vol. 17 (1). Date of Electronic Publication: 2026 Jan 29. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-026-68716-6 |
